Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic CancerSusan Tsai, Douglas B. Evans, Bradley A. Erickson et al.|Annals of Surgery|2018Cited by 237
Locally advanced pancreas cancer: Staging and goals of therapyN. Chatzizacharias, Kathleen K. Christians, Susan Tsai et al.|Surgery|2018Cited by 58
Distal splenorenal and mesocaval shunting at the time of pancreatectomyMariana Chávez, Kathleen K. Christians, Susan Tsai et al.|Surgery|2018Cited by 20
Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosisManav Bhalla, Parag Tolat, Mohammed Aldakkak et al.|Abdominal Radiology|2017Cited by 11
Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancerAshley N. Krepline, Rebecca Y. Kim, Jennifer L. Geurts et al.|Surgery|2020Cited by 9